pneumococcal disease
Vaccines · 2009–2025
9decisions
7medicines
4carried consumer input
3individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| 21-valent pneumococcal conjugate vaccine Prevention of pneumococcal disease in non-Indigenous adults aged ≥70 years (or ≥65 years per ATAGI recommendation), Aboriginal and Torres Strait Islander… | Nov 2025 | Recommended with restriction | unclear |
| pneumococcal conjugate vaccine, 15-valent Active immunisation for the prevention of pneumococcal disease caused by Streptococcus pneumoniae serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F,… | Mar 2023 | Recommended with restriction | input received Lung Foundation Australia |
| pneumococcal conjugate vaccine, 20-valent Prevention of pneumococcal disease caused by Streptococcus pneumoniae in paediatric populations including infants aged 12 months or younger and children with… | Nov 2023 | Recommended | input received Immunisation Foundation |
| pneumococcal polysaccharide conjugate vaccine, 13-valent Prevention of pneumococcal disease (community-acquired pneumonia and invasive pneumococcal disease) in children aged ≥5 to <15 years at increased risk,… | Nov 2018 | Not recommended | input received |
| pneumococcal conjugate vaccine, 13-valent Prevention of pneumococcal disease (community-acquired pneumonia and invasive pneumococcal disease) in pneumococcal vaccine-naive non-Indigenous adults aged 65… | Jul 2016 | Recommended | 3 individuals Lung Foundation Australia |
| pneumococcal polysaccharide conjugate vaccine, 13-valent Immunisation against pneumococcal disease in infants and children at 2, 4 and 6 months of age, with medically at risk children receiving a fourth dose at 12… | Jul 2010 | Recommended | unclear |
| a single supplementary (catch-up) dose of 13vPCV for children aged between 12 and 35 months who have completed primary vaccination with 3 doses of 7vPCV,… | Nov 2010 | Recommended with restriction | no section in document |
| pneumococcal polysaccharide conjugate vaccine, 13-valent Immunisation against pneumococcal disease in infants and children at 2, 4 and 6 months of age, with medically at risk children receiving a fourth dose at 12… | 2010 | Recommended | unclear |
| pneumococcal polysaccharide conjugate vaccine For immunisation of all Australian infants and children from the age of eight weeks to two years of age against disease caused by Streptococcus pneumoniae… | 2009 | Recommended with restriction | no section in document |
Who spoke
Lung Foundation Australia · Immunisation Foundation
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 4 of 5 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.